The meeting provided a spectrum of practice-changing studies, early-stage data for novel therapies, and advances in notable trends such as immuno-oncology and cellular therapy. The Axiom Healthcare Strategies team attended the meeting to understand and discuss the data presented with thought leaders, and here we summarize our key takeaways.
ASCO 2019 White Paper
.pdf
Download PDF • 317KB